NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf022 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Bhuvic Patel und 21 weiteren Autor:innen. Beteiligte Einrichtung: Taylor Department of Neurological Surgery, Washington University School of Medicine, St Louis, MO 63110, United States. Hauptthemen laut MEDLINE: Radiation Tolerance, Meningioma, Neurofibromin 2, Loss of Function Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 2019-2020 Neurosurgery Research and Education Fund, Academy of Neurological Surgeons Research Fellowship Grant, Washington University School of Medicine Dean's Medical Student Research.
Abstract (Originalsprache)
Background
World Health Organization Grade 2 meningiomas (G2Ms) often recur and resist therapies. Grade 2 meningiomas with histopathological necrosis have been associated with worse local control (LC) after radiation therapy, but the drivers and biomarkers of radiation resistance in G2Ms remain unknown.
Methods
We performed genetic sequencing and histopathological analysis of 113 G2Ms and investigated the role of genetic and microenvironmental factors on clonogenic survival after ionizing radiation. We performed transcriptional profiling of our in vitro model and 18 human G2M tumors by bulk RNA sequencing as well as 8 G2Ms by single nuclei RNA sequencing.
Results
NF2 loss-of-function (LOF) mutations were associated with necrosis in G2Ms (P = .0127). Tumors with NF2 mutation and necrosis had worse post-radiation LC compared to NF2 wildtype tumors without necrosis (P = .035). Under hypoxic conditions, NF2 knockdown increased radiation resistance in vitro (P < .001). Bulk RNA sequencing revealed NF2- and hypoxia-specific changes and a 50-gene set signature specific to radiation-resistant, NF2 knockdown, and hypoxic cells, which distinguished NF2 mutant/necrotic patient G2Ms by unsupervised clustering. Enrichment analysis revealed downregulation of apoptosis pathway genes and upregulation of proliferation-associated genes and genes normally downregulated after UV radiation exposure in NF2-mutant/necrotic tumor cells, which were validated with functional assays.
Conclusions
NF2 LOF in the setting of hypoxia confers radiation resistance through transcriptional programs that reduce apoptosis and promote proliferation. These pathways may identify tumors resistant to radiation and represent therapeutic targets that in the future could improve LC in patients with radiation resistant G2Ms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Taylor Department of Neurological Surgery, Washington University School of Medicine, St Louis, MO 63110, United States.
- The Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, United States.
- Department of Neurological Surgery, Baylor School of Medicine, Houston, TX 77030, United States.
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, United States.
- Department of Pathology, University of Manitoba, Winnipeg, Canada.
- Department of Radiology, Washington University School of Medicine, St Louis, MO 63110, United States.
ORCID-Profile: Bhuvic Patel, Sangami Pugazenthi, Collin W English, Vijay Nitturi, Shree S Pari, Hsiang-Chih Lu, Patrick DeSouza, Sonika Dahiya, Albert H Kim
Förderung
- 2019-2020 Neurosurgery Research and Education Fund
- Academy of Neurological Surgeons Research Fellowship Grant
- Washington University School of Medicine Dean's Medical Student Research
- 2023 NREF Medical Student Summer Research
- 2023 American Brain Tumor Association Jack & Fay Netchin Medical Student Summer
- Cancer Prevention and Research Institute of Texas
- an and Dan Duncan Neurological Research Institute
- Neurological Research Institute
Zitieren
APA
Patel, B., Pugazenthi, S., English, C. W., Nitturi, V., Pari, S. S., Mahlokozera, T., Leidig, W. A., Lu, H. C., Yang, A., Roberts, K., DeSouza, P., McGeehan, K. P., Mao, D. D., Sinha, N., Ippolito, J. E., Dahiya, S., Petti, A., Yano, H., Klisch, T. J., …, & Kim, A. H. (2025). NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf022
Vancouver
Patel B, Pugazenthi S, English CW, Nitturi V, Pari SS, Mahlokozera T, et al. NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf022
BibTeX
@article{Patel2025,
author = {Patel, Bhuvic and Pugazenthi, Sangami and English, Collin W and Nitturi, Vijay and Pari, Shree S and Mahlokozera, Tatenda and Leidig, William A and Lu, Hsiang-Chih and Yang, Alicia and Roberts, Kaleigh and DeSouza, Patrick and McGeehan, Kyle P and Mao, Diane D and Sinha, Namita and Ippolito, Joseph E and Dahiya, Sonika and Petti, Allegra and Yano, Hiroko and Klisch, Tiemo J and Harmanci, Akdes S and Patel, Akash J and Kim, Albert H},
title = {NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf022}
}
EUVIMED